CN1244798A - 磺酸或磺酰氨基n－(杂芳烷基)－氮杂环酰胺化合物 - Google Patents
磺酸或磺酰氨基n－(杂芳烷基)－氮杂环酰胺化合物 Download PDFInfo
- Publication number
- CN1244798A CN1244798A CN97181387A CN97181387A CN1244798A CN 1244798 A CN1244798 A CN 1244798A CN 97181387 A CN97181387 A CN 97181387A CN 97181387 A CN97181387 A CN 97181387A CN 1244798 A CN1244798 A CN 1244798A
- Authority
- CN
- China
- Prior art keywords
- sulfonic acid
- methyl
- oxo
- pyrrolidine
- amide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
- A61K31/4725—Non-condensed isoquinolines, e.g. papaverine containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3315996P | 1996-12-13 | 1996-12-13 | |
| US60/033,159 | 1996-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1244798A true CN1244798A (zh) | 2000-02-16 |
Family
ID=21868858
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN97181387A Pending CN1244798A (zh) | 1996-12-13 | 1997-12-03 | 磺酸或磺酰氨基n－(杂芳烷基)－氮杂环酰胺化合物 |
Country Status (23)
| Country | Link |
|---|---|
| EP (1) | EP0944386B1 (enExample) |
| JP (1) | JP4223560B2 (enExample) |
| KR (1) | KR20000057528A (enExample) |
| CN (1) | CN1244798A (enExample) |
| AP (1) | AP1032A (enExample) |
| AT (1) | ATE224192T1 (enExample) |
| AU (1) | AU726637B2 (enExample) |
| BG (1) | BG103558A (enExample) |
| BR (1) | BR9713921A (enExample) |
| CA (1) | CA2274686C (enExample) |
| DE (1) | DE69715658T2 (enExample) |
| DK (1) | DK0944386T3 (enExample) |
| EA (1) | EA002817B1 (enExample) |
| ES (1) | ES2184145T3 (enExample) |
| HU (1) | HUP9904188A3 (enExample) |
| IL (1) | IL130152A0 (enExample) |
| NO (1) | NO312416B1 (enExample) |
| OA (1) | OA11062A (enExample) |
| PL (1) | PL333921A1 (enExample) |
| PT (1) | PT944386E (enExample) |
| SK (1) | SK71299A3 (enExample) |
| WO (1) | WO1998025611A1 (enExample) |
| ZA (1) | ZA9711207B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104098497A (zh) * | 2014-06-17 | 2014-10-15 | 王庚禹 | 一种新的酰胺类化合物 |
| CN104136030A (zh) * | 2011-12-21 | 2014-11-05 | 赛诺菲 | 磺酰基氨基吡咯烷酮衍生物，及其制备及治疗应用 |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6281227B1 (en) * | 1996-12-13 | 2001-08-28 | Aventis Pharma Deutschland Gmbh | Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds |
| US6602864B1 (en) * | 1996-12-13 | 2003-08-05 | Aventis Pharma Deutschland Gmbh | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds |
| IL123986A (en) * | 1997-04-24 | 2011-10-31 | Organon Nv | Medicinal compounds |
| AR016817A1 (es) | 1997-08-14 | 2001-08-01 | Smithkline Beecham Plc | Derivados de fenilurea o feniltiourea, procedimiento para su preparacion, coleccion de compuestos, compuestos intermediarios, composicion farmaceutica,metodo de tratamiento y uso de dichos compuestos para la manufactura de un medicamento |
| AU8875798A (en) | 1997-08-29 | 1999-03-22 | Proteus Molecular Design Ltd | Meta-benzamidine derivatives as serin protease inhibitors |
| DE69833036T2 (de) | 1997-09-30 | 2006-06-22 | Daiichi Pharmaceutical Co., Ltd. | Sulfonylderivate |
| AU753675B2 (en) | 1998-03-19 | 2002-10-24 | Ajinomoto Co., Inc. | Aminoisoquinoline derivatives |
| CA2340100A1 (en) * | 1998-08-11 | 2000-02-24 | Daiichi Pharmaceutical Co., Ltd. | Novel sulfonyl derivatives |
| CA2408913A1 (en) | 2000-05-16 | 2001-11-22 | Takeda Chemical Industries, Ltd. | Melanin-concentrating hormone antagonist |
| GB0114004D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| GB0114005D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
| GB0127568D0 (en) | 2001-11-16 | 2002-01-09 | Glaxo Group Ltd | Chemical compounds |
| AU2003232173A1 (en) * | 2002-06-12 | 2003-12-31 | Qsi Pharma A/S | Compounds and methods for controlling bacterial virulence |
| PT1569912E (pt) | 2002-12-03 | 2015-09-15 | Pharmacyclics Llc | Derivados 2-(2-hidroxibifenil-3-il)-1h-benzoimidazole-5- carboxamidina como inibidores do fator viia |
| EP1784410A4 (en) * | 2004-08-09 | 2009-07-15 | Glaxo Group Ltd | ANTIBACTERIAL AGENTS |
| FR2890072A1 (fr) | 2005-09-01 | 2007-03-02 | Fournier S A Sa Lab | Nouveaux composesde pyrrolopyridine |
| JP5147401B2 (ja) * | 2005-09-06 | 2013-02-20 | 塩野義製薬株式会社 | Ｐｇｄ２受容体アンタゴニスト活性を有するインドールカルボン酸誘導体 |
| FR2955110A1 (fr) | 2010-01-08 | 2011-07-15 | Fournier Lab Sa | Nouveaux derives de type pyrrolopyridine benzoique |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4121947A1 (de) * | 1991-07-03 | 1993-01-07 | Basf Ag | 2-(3-(4-amidino-phenyl))-propionsaeurederivate, ihre herstellung und verwendung |
| JPH10503176A (ja) * | 1994-06-17 | 1998-03-24 | コーバス インターナショナル， インコーポレイテッド | 酵素インヒビターとしての３−アミノ−２−オキソ−１−ピペリジン酢酸誘導体 |
| US5612353A (en) * | 1995-06-07 | 1997-03-18 | Rhone-Poulenc Rorer Pharmaceuticals Inc. | Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) N-[(aminoiminomethyl)phenylalkyl]-azaheterocyclylamide compounds |
-
1997
- 1997-12-03 ES ES97951573T patent/ES2184145T3/es not_active Expired - Lifetime
- 1997-12-03 DK DK97951573T patent/DK0944386T3/da active
- 1997-12-03 DE DE69715658T patent/DE69715658T2/de not_active Expired - Lifetime
- 1997-12-03 EA EA199900542A patent/EA002817B1/ru not_active IP Right Cessation
- 1997-12-03 CN CN97181387A patent/CN1244798A/zh active Pending
- 1997-12-03 IL IL13015297A patent/IL130152A0/xx unknown
- 1997-12-03 JP JP52684498A patent/JP4223560B2/ja not_active Expired - Fee Related
- 1997-12-03 EP EP97951573A patent/EP0944386B1/en not_active Expired - Lifetime
- 1997-12-03 AP APAP/P/1999/001552A patent/AP1032A/en active
- 1997-12-03 SK SK712-99A patent/SK71299A3/sk unknown
- 1997-12-03 HU HU9904188A patent/HUP9904188A3/hu unknown
- 1997-12-03 AU AU55182/98A patent/AU726637B2/en not_active Ceased
- 1997-12-03 WO PCT/US1997/022406 patent/WO1998025611A1/en not_active Ceased
- 1997-12-03 KR KR1019990705236A patent/KR20000057528A/ko not_active Withdrawn
- 1997-12-03 AT AT97951573T patent/ATE224192T1/de not_active IP Right Cessation
- 1997-12-03 BR BR9713921A patent/BR9713921A/pt not_active IP Right Cessation
- 1997-12-03 PL PL97333921A patent/PL333921A1/xx unknown
- 1997-12-03 PT PT97951573T patent/PT944386E/pt unknown
- 1997-12-03 CA CA002274686A patent/CA2274686C/en not_active Expired - Fee Related
- 1997-12-12 ZA ZA9711207A patent/ZA9711207B/xx unknown
-
1999
- 1999-06-11 NO NO19992853A patent/NO312416B1/no unknown
- 1999-06-11 OA OA9900124A patent/OA11062A/en unknown
- 1999-07-07 BG BG103558A patent/BG103558A/xx unknown
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104136030A (zh) * | 2011-12-21 | 2014-11-05 | 赛诺菲 | 磺酰基氨基吡咯烷酮衍生物，及其制备及治疗应用 |
| CN104136030B (zh) * | 2011-12-21 | 2017-03-01 | 赛诺菲 | 磺酰基氨基吡咯烷酮衍生物，及其制备及治疗应用 |
| CN104098497A (zh) * | 2014-06-17 | 2014-10-15 | 王庚禹 | 一种新的酰胺类化合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| DE69715658T2 (de) | 2003-05-22 |
| NO312416B1 (no) | 2002-05-06 |
| NO992853D0 (no) | 1999-06-11 |
| AU726637B2 (en) | 2000-11-16 |
| NO992853L (no) | 1999-08-10 |
| ES2184145T3 (es) | 2003-04-01 |
| OA11062A (en) | 2002-03-11 |
| DK0944386T3 (da) | 2003-01-27 |
| CA2274686A1 (en) | 1998-06-18 |
| EP0944386A4 (en) | 2001-04-11 |
| PT944386E (pt) | 2003-01-31 |
| DE69715658D1 (de) | 2002-10-24 |
| ZA9711207B (en) | 1998-07-20 |
| CA2274686C (en) | 2009-02-03 |
| AP1032A (en) | 2001-12-24 |
| AP9901552A0 (en) | 1999-06-30 |
| KR20000057528A (ko) | 2000-09-25 |
| PL333921A1 (en) | 2000-01-31 |
| EP0944386A1 (en) | 1999-09-29 |
| EP0944386B1 (en) | 2002-09-18 |
| EA199900542A1 (ru) | 2000-02-28 |
| BG103558A (en) | 2000-04-28 |
| HUP9904188A3 (en) | 2003-02-28 |
| IL130152A0 (en) | 2000-06-01 |
| SK71299A3 (en) | 2000-12-11 |
| AU5518298A (en) | 1998-07-03 |
| WO1998025611A1 (en) | 1998-06-18 |
| HUP9904188A1 (hu) | 2000-06-28 |
| ATE224192T1 (de) | 2002-10-15 |
| EA002817B1 (ru) | 2002-10-31 |
| JP4223560B2 (ja) | 2009-02-12 |
| JP2001506630A (ja) | 2001-05-22 |
| BR9713921A (pt) | 2000-03-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1244798A (zh) | 磺酸或磺酰氨基n－(杂芳烷基)－氮杂环酰胺化合物 | |
| CN1221529C (zh) | 取代的n－[(氨基亚氨基甲基或氨甲基)苯基]丙基酰胺 | |
| CN1255403C (zh) | 用作磷酸二酯酶抑制剂的β－咔啉衍生物 | |
| CN1291892A (zh) | 取代的氧代氮杂杂环基因子Xa抑制剂 | |
| US6281227B1 (en) | Sulfonic acid sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| CN1063446C (zh) | 作为促性腺激素释放激素拮抗剂的噻吩并吡啶衍生物 | |
| CN1454211A (zh) | 作为Xa因子抑制剂的含氮杂双环化合物 | |
| CN1093856C (zh) | 取代的磺酸n－[(氨基亚氨基甲基)苯基烷基]－氮杂环酰胺化合物 | |
| US20100120838A1 (en) | Compounds for the treatment of inflammatory disorders | |
| CN1208347A (zh) | 取代的n－[(氨基亚氨基甲基和氨基甲基)苯基]丙基酰胺 | |
| CN1143323A (zh) | 双环纤维蛋白原拮抗剂 | |
| HK1052508A1 (zh) | 作为凝血因子xa抑制剂的含氮杂双环 | |
| CZ294600B6 (cs) | Deriváty indolu s protizánětlivou aktivitou a farmaceutické prostředky, které je obsahují | |
| CN1735612A (zh) | 抗感染剂 | |
| CN1265649A (zh) | 作为mcp－1受体拮抗剂的吲哚衍生物 | |
| CN1291095A (zh) | 化学化合物 | |
| CN1639119A (zh) | 取代的2－氨基－环烷烃甲酰胺和它们作为半胱氨酸蛋白酶抑制剂的用途 | |
| AU758642B2 (en) | Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds | |
| CN1620434A (zh) | 作为因子Xa抑制剂的吡咯烷－2－酮类 | |
| CN1333766A (zh) | 取代的(氨基亚氨基甲基或氨基甲基)苯并杂芳基化合物 | |
| CN1245400C (zh) | N－取代苯并噻唑磺胺衍生物 | |
| CN1538845A (zh) | 作为Xa因子抑制剂的苯基衍生物 | |
| HK1030741A (en) | Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds | |
| HK1035489A (en) | Substituted oxoazaheterocyclyl factor xa inhibitors | |
| HK1022685B (en) | Substituted n-[ (aminoiminomethyly or aminomethyl) phenyl] propyl amides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| CI01 | Publication of corrected invention patent application |
Correction item: Name of the sixth inventor Correct: Baker Mark R False: Becker Richard Number: 7 Page: 87 Volume: 16 |
|
| CI02 | Correction of invention patent application |
Correction item: Name of the sixth inventor Correct: Baker Mark R False: Becker Richard Number: 7 Page: The title page Volume: 16 |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: THE SIXTH NAME OF THE INVENTOR; FROM: BAKER ROLAND TO: M. R. BECKER |
|
| ERR | Gazette correction |
Free format text: CORRECT: THE SIXTH NAME OF THE INVENTOR; FROM: BAKER ROLAND TO: M. R. BECKER |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1030741 Country of ref document: HK |